316 related articles for article (PubMed ID: 35611897)
21. Amyotrophic lateral sclerosis.
Feldman EL; Goutman SA; Petri S; Mazzini L; Savelieff MG; Shaw PJ; Sobue G
Lancet; 2022 Oct; 400(10360):1363-1380. PubMed ID: 36116464
[TBL] [Abstract][Full Text] [Related]
22. Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Joilin G; Gray E; Thompson AG; Talbot K; Leigh PN; Newbury SF; Turner MR; Hafezparast M
Ann Med; 2022 Dec; 54(1):3069-3078. PubMed ID: 36314539
[TBL] [Abstract][Full Text] [Related]
23. Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives.
Afonso GJM; Cavaleiro C; Valero J; Mota SI; Ferreiro E
Cells; 2023 Jul; 12(13):. PubMed ID: 37443797
[TBL] [Abstract][Full Text] [Related]
24. Emerging molecular biomarker targets for amyotrophic lateral sclerosis.
Costa J; de Carvalho M
Clin Chim Acta; 2016 Apr; 455():7-14. PubMed ID: 26774696
[TBL] [Abstract][Full Text] [Related]
25. Neurochemical biomarkers in amyotrophic lateral sclerosis.
Verde F; Silani V; Otto M
Curr Opin Neurol; 2019 Oct; 32(5):747-757. PubMed ID: 31403480
[TBL] [Abstract][Full Text] [Related]
26. Amyotrophic Lateral Sclerosis: Current Status in Diagnostic Biomarkers.
Kadena K; Vlamos P
Adv Exp Med Biol; 2020; 1195():179-187. PubMed ID: 32468476
[TBL] [Abstract][Full Text] [Related]
27. Otolaryngologist's role in the diagnosis of amyotrophic lateral sclerosis.
Costa JB; Pereira D; Duarte D; Viana M
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33622737
[TBL] [Abstract][Full Text] [Related]
28. A Machine Learning Approach for Highlighting microRNAs as Biomarkers Linked to Amyotrophic Lateral Sclerosis Diagnosis and Progression.
Lauria G; Curcio R; Tucci P
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254647
[TBL] [Abstract][Full Text] [Related]
29. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).
Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J
Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844
[TBL] [Abstract][Full Text] [Related]
30. Evolving markers in amyotrophic lateral sclerosis.
Chen X; Zhou L; Cui C; Sun J
Adv Clin Chem; 2023; 114():225-246. PubMed ID: 37268333
[TBL] [Abstract][Full Text] [Related]
31. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine.
Rocha AJ; Maia Júnior AC
Arq Neuropsiquiatr; 2012 Jul; 70(7):532-9. PubMed ID: 22836461
[TBL] [Abstract][Full Text] [Related]
32. Misdiagnoses in a Brazilian population with amyotrophic lateral sclerosis.
Borghetti VS; Cintra VP; Ramos JO; Marques VD; Onofre PT; Santana VAS; Bezerra LFP; Tomaselli PJ; Santos ACJD; Sobreira CFDR; Marques W
Arq Neuropsiquiatr; 2022 Jul; 80(7):676-680. PubMed ID: 36254439
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic delay in amyotrophic lateral sclerosis.
Gwathmey KG; Corcia P; McDermott CJ; Genge A; Sennfält S; de Carvalho M; Ingre C
Eur J Neurol; 2023 Sep; 30(9):2595-2601. PubMed ID: 37209406
[TBL] [Abstract][Full Text] [Related]
34. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.
Mead RJ; Shan N; Reiser HJ; Marshall F; Shaw PJ
Nat Rev Drug Discov; 2023 Mar; 22(3):185-212. PubMed ID: 36543887
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
Rinchetti P; Rizzuti M; Faravelli I; Corti S
Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
[TBL] [Abstract][Full Text] [Related]
36. Natural history and remarkable psychiatric state of late-onset amyotrophic lateral sclerosis in China.
Huang S; Zheng M; Lin J; Huang P; Chen W; He R; Yao X
Acta Neurol Scand; 2022 Jul; 146(1):24-33. PubMed ID: 35187661
[TBL] [Abstract][Full Text] [Related]
37. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
[TBL] [Abstract][Full Text] [Related]
38. Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.
Teruel-Peña B; Gómez-Urquiza JL; Suleiman-Martos N; Prieto I; García-Cózar FJ; Ramírez-Sánchez M; Fernández-Martos C; Domínguez-Vías G
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108335
[TBL] [Abstract][Full Text] [Related]
39. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
Deeb O; Nabulsi M
Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
[TBL] [Abstract][Full Text] [Related]
40. Advances in genetics research in the pathogenesis of amyotrophic lateral sclerosis.
Wang Y; Yi H; Liao Q; Bi F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1483-1489. PubMed ID: 33473007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
